Epidemiological profile of Covid-19 morbidity and mortality in the State of Piauí: an update of the current scenario

Authors

DOI:

https://doi.org/10.33448/rsd-v9i8.6091

Keywords:

Coronavirus; Epidemiology; Morbidity.

Abstract

The new Coronavirus was defined as SARS-CoV-2 in late 2019. It is responsible for the disease classified as COVID-19. The present study aimed to discuss the deaths caused by covid-19 in the state of Piauí during the pandemic, and its correlation with the comorbidities associated with patients and their age group. It is a descriptive research, carried out from the epidemiological survey of cases and deaths of Covid-19 in the State of Piauí. The age range, comorbidities and risk factors identified among the deaths were analyzed, where from these data, lethality was calculated and plotted in tables. The state of Piauí has10,153 thousand confirmed cases, with the capital Teresina, with the largest number, with 43% of cases followed by the coastal city of Parnaíba with 13%, Barras 4%, Campo Maior 3% and Picos 3%. Teresina still had the highest number of deaths with 196 deaths, followed by Parnaíba (n = 31), Barras (n = 8), Campo Maior (n = 7), Picos, Esperantina and Piripiri (n = 6). Heart diseases had the highest frequency in cases of death by Covid-19, with 48.61% of cases, followed by diabetes with 23.61%, CND or DNM 4.63%, Obesity 3.7%. The age group from 70 to 79 years old most affected with 30%, followed by 80 years old or more with 26.67%. Thus, it can be inferred how essential the structural development of public health in Piauí is, especially in emerging centers, as well as the priority preservation of people who have comorbidities and with high age.

Author Biographies

Tiago Medeiros da Silva, Universidade Federal do Piaui

Departamento de Biologia

Luis Eduardo Alencar Silva, Faculdade de Medicina Estácio

Departamento de Medicina

Alan Rodrigues da Silva, Hospital Geral de Fortaleza

Departamento de Farmácia clínica

Lara Christina da Silva Cavalcante, Centro Universitário Uninovafapi

Departamento de Medicina

Sufia de Jesus Costa, Associação de ensino superior do Piaui

Departamento de Farmacia

Renata Pereira da Silva, Centro Universitário Santo Agostinho

Departamento de Farmácia

Maria Camila Leal de Moura, Universidade Federal do Piaui

Departamento de Farmácia clínica

Amanda da Silva Costa, Instituto Brasil de Pós Graduação

Departamento de Farmacologia

Maria Francinete do Nascimento Silva, Centro Universitário Unifacid/Wyden

Departamento de enfermagem

Márcia de Morais Sousa, Centro Universitário Unifacid/Wyden

Departamento de enfermagem

Roberta Pires de Sousa Matos, Instituto Brasil de Pós Graduação

Departamento de Farmacologia

Layane Aiala de Sousa Lopes, Centro Universitário Santo Agostinho

Departamento de farmácia

Rosana de Oliveira Pereira, Centro Universitário Unifacid/Wyden

Departamento de Farmácia

Gilberto de Sousa Jr, Centro Universitário Unifacid/Wyden

Departamento de Medicina

References

Ahmad, A., Rehman, M. U., & Alkharfy, K. M. (2020). An alternative approach to minimize the risk of coronavirus (Covid-19) and similar infections. European Review for Medical and Pharmacological Sciences, 24(7), 4030–4034.

https://doi.org/10.26355/EURREV_202004_20873

Ann, J. M., Warshaw, M., Compagnucci, A., Saidi, Y., Harrison, L., Turkova, A., Tudor-Williams, G. A. (2017). Hepatic, Renal, Hematologic, and Inflammatory Markers in HIV-Infected Children on Long-term Suppressive Antiretroviral Therapy. Journal of the Pediatric Infectious Diseases Society, 6(3). https://doi.org/10.1093/JPIDS/PIX050

Akhmerov, A., & Marbán, E. (2020). COVID-19 and the Heart. Circulation Research, 126, 1443–1455. https://doi.org/10.1161/CIRCRESAHA.120.317055

Bansal, M. (2020). Cardiovascular disease and COVID-19. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14(3), 247–250.

https://doi.org/10.1016/j.dsx.2020.03.013

Batista, F. M. A., Mascarenhas, M. D. M., Marinelli, N. P., Albuquerque, L. P. A., Rodrigues, M. T. P., Vieira, M. A. C. S., & Sousa, I. D. B. (2020). COVID-19 in Piauí: Initial scenario and perspectives for coping. Revista Da Sociedade Brasileira de Medicina Tropical, 53. https://doi.org/10.1590/0037-8682-0175-2020

Bloomgarden, Z. T. (2020). Diabetes and COVID‐19. Journal of Diabetes, 12(4), 347–348. https://doi.org/10.1111/1753-0407.13027

Boccardi, V., Ruggiero, C., & Mecocci, P. (2020, June 1). COVID-19: A geriatric emergency. Geriatrics (Switzerland), Vol. 5. https://doi.org/10.3390/GERIATRICS5020024

Bonanad, C., García-Blas, S., Tarazona-Santabalbina, F. J., Díez-Villanueva, P., Ayesta, A., Forés, J. S., Martínez-Sellés, M. (2020). [Coronavirus: the geriatric emergency of 2020. Joint document of the Geriatric Cardiology Section of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology]. Revista Espanola de Cardiologia. https://doi.org/10.1016/j.recesp.2020.03.027

Bonanad, C., García-Blas, S., Tarazona-Santabalbina, F. J., Díez-Villanueva, P., Ayesta, A., Sanchis Forés, J., Scientific societies of the authors. The contributing authors are members of the following scientific bodies. (2020). Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology. Revista Espanola de Cardiologia (English Ed.). https://doi.org/10.1016/j.rec.2020.05.001

Bonita, R., Beaglehole, R., & Kjellström, T. (n.d.). Epidemiologia Básica 2 a edição.

Cheng, H., Wang, Y., & Wang, G. Q. (2020). Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. Journal of Medical Virology. https://doi.org/10.1002/jmv.25785

Coronavírus Brasil. (n.d.). Retrieved June 15, 2020, from https://covid.saude.gov.br/

Leo, D., & Trabucchi, M. (2020). COVID-19 and the fears of italian senior citizens. International Journal of Environmental Research and Public Health, 17(10). https://doi.org/10.3390/ijerph17103572

de Oliveira, I. S., Borges Crosara, P. F. T., Cassali, G. D., dos Reis, D. C., Rodrigues, D. S., Nunes, F. B., & Guimarães, R. E. S. (2016). Azithromycin for the treatment of eosinophilic nasal polyposis: Clinical and histologic analysis. Allergy & Rhinology, 7(2), 55–61. https://doi.org/10.2500/ar.2016.7.0160

Dietz, W., & Santos‐Burgoa, C. (2020). Obesity and its Implications for COVID‐19 Mortality. Obesity, 28(6), 1005–1005. https://doi.org/10.1002/oby.22818

Díez-Villanueva, P., Arizá-Solé, A., Vidán, M. T., Bonanad, C., Formiga, F., Sanchis, J., & Martínez-Sellés, M. (2019). Recommendations of the Geriatric Cardiology Section of the Spanish Society of Cardiology for the Assessment of Frailty in Elderly Patients With Heart Disease. Revista Española de Cardiología (English Edition), 72(1), 63–71. https://doi.org/10.1016/j.rec.2018.06.035

Fontana, F., Alfano, G., Mori, G., Amurri, A., Lorenzo, T., Ballestri, M., Cappelli, G. (2020). Covid-19 pneumonia in a kidney transplant recipient successfully treated with Tocilizumab and Hydroxychloroquine. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. https://doi.org/10.1111/ajt.15935

Gosain, R., Abdou, Y., Singh, A., Rana, N., Puzanov, I., & Ernstoff, M. S. (2020, May 1). COVID-19 and Cancer: a Comprehensive Review. Current Oncology Reports, 22. https://doi.org/10.1007/s11912-020-00934-7

Guidon, A. C., & Amato, A. A. (2020). COVID-19 and neuromuscular disorders. Neurology, 94(22), 959–969. https://doi.org/10.1212/WNL.0000000000009566

Huang, X., Wei, F., Hu, L., Wen, L., & Chen, K. (2020). Epidemiology and clinical characteristics of COVID-19. Archives of Iranian Medicine, 23, 268–271. https://doi.org/10.34172/aim.2020.09

Li, Y., & Xia, L. (2020). Coronavirus disease 2019 (COVID-19): Role of chest CT in diagnosis and management. American Journal of Roentgenology, 214(6), 1280–1286. https://doi.org/10.2214/AJR.20.22954

Marinelli, N. P. N. P., Albuquerque, L. P. de A. P. A., Sousa, I. D. B., Batista, F. M. A. A., Mascarenhas, M. D. M. M. D. M., & Rodrigues, M. T. P. (2020). Evolution of indicators and service capacity at the beginning of the COVID-19 epidemic in Northeast Brazil, 2020. Epidemiologia e Servicos de Saude : Revista Do Sistema Unico de Saude Do Brasil, 29(3), e2020226. https://doi.org/10.5123/S1679-49742020000300008

Miller, A. J., & Arnold, A. C. (2019, April 1). The renin–angiotensin system in cardiovascular autonomic control: recent developments and clinical implications. Clinical Autonomic Research, 29, 231–243. https://doi.org/10.1007/s10286-018-0572-5

Painel Covid-19 • Piauí › Página 1. (n.d.). Retrieved June 15, 2020, from https://datastudio.google.com/u/0/reporting/a6dc07e9-4161-4b5a-9f2a-6f9be486e8f9/page/2itOB

Pal, R., & Bhadada, S. K. (2020). COVID-19 and diabetes mellitus: An unholy interaction of two pandemics. Diabetes & Metabolic Syndrome, 14(4), 513–517. https://doi.org/10.1016/j.dsx.2020.04.049

Scheen, A. J. (2020, May 27). Obésité et risque de COVID-19 sévère. Revue Medicale Suisse, 16, 1115–1119. NLM (Medline).

Simko, F., Baka, T., Krajcirovicova, K., Repova, K., Aziriova, S., Zorad, S., Paulis, L. (2018). Effect of melatonin on the renin-angiotensin-aldosterone system in L-NAME-Induced hypertension. Molecules, 23(2). https://doi.org/10.3390/molecules23020265

Soares, A., Dorlivete, P., Shitsuka, M., Parreira, F. J., & Shitsuka, R. (n.d.). Metodologia da pesquisa científica.

Van der Heijden, E. H. M., Hartgring, S. A. Y., Kruize, A. A., Radstake, T. R. D. J., & Van Roon, J. A. G. (2019). Additive immunosuppressive effect of leflunomide and hydroxychloroquine supports rationale for combination therapy for Sjögren’s syndrome. Expert Review of Clinical Immunology, 15(7), 801–808. https://doi.org/10.1080/1744666X.2019.1624527

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., & Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395(10229), 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3

Published

20/07/2020

How to Cite

SILVA, T. M. da; SILVA, L. E. A.; SILVA, A. R. da; CAVALCANTE, L. C. da S.; COSTA, S. de J.; SILVA, R. P. da; MOURA, M. C. L. de; COSTA, A. da S.; ROCHA, L. R.; SILVA, M. F. do N.; SOUSA, M. de M.; MATOS, R. P. de S.; LOPES, L. A. de S.; PEREIRA, R. de O.; SOUSA JR, G. de; SANTOS, J. C. Epidemiological profile of Covid-19 morbidity and mortality in the State of Piauí: an update of the current scenario. Research, Society and Development, [S. l.], v. 9, n. 8, p. e803986091, 2020. DOI: 10.33448/rsd-v9i8.6091. Disponível em: https://www.rsdjournal.org/index.php/rsd/article/view/6091. Acesso em: 25 apr. 2024.

Issue

Section

Health Sciences